Kolibri is revolutionizing the way we grow cells at scale using sound. Showing 100x increase in cell density and 50x reduction in production costs, Kolibri patented bioreactors which help our partners in drug development unlock patient access to gene therapies. Being cell-agnostic and scalable, Kolibri’s process has significant potential across a range of high-value cell-based therapies – or in the cellular agriculture space more broadly.